Dermira (DERM) Tops Q3 EPS by $1.15

Dermira (NASDAQ: DERM) reported Q3 EPS of $0.99, $1.15 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $34.54 million versus the consensus estimate of $16.9 million.

For earnings history and earnings-related data on Dermira (DERM) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• Oracle raises full year profit guidance, stock rises after hours
• Copart (CPRT) Misses Q4 EPS by 4c